The Neurovirology working group aims to determine whether there are certain clades, variants or mutations are associated with neurological diseases of different clinical phenotypes; this includes looking for neurovirulent strains by comparing virus from the periphery and the central nervous system, as well as looking for variants associated with other neurological manifestations, e.g. encephalopathy.



Back to: COVID-19 Clinical Neuroscience Study (COVID-CNS)